Optimizing vaccine development

Cellular Microbiology

Volumn 13, Issue 7, 2011, Pages 934-942

  Hoft, Daniel F ^a   Brusic, Vladimir ^b   Sakala, Isaac G ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; COMPLEMENTARY DNA; CPG OLIGODEOXYNUCLEOTIDE; CUTANEOUS LYMPHOCYTE ASSOCIATED ANTIGEN; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 4; INTERLEUKIN 6; LEISHMANIA VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; METFORMIN; PERFORIN; RAPAMYCIN; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VACCINE; VIRULENCE FACTOR;

CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; DRUG QUALITY; DRUG SAFETY; EMULSION; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; INFECTION PREVENTION; LONG TERM MEMORY; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REGULATORY T LYMPHOCYTE; SHORT SURVEY; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL; TH3 CELL; TRANSCRIPTION INITIATION; VACCINE PRODUCTION;

ADJUVANTS, IMMUNOLOGIC; BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; IMMUNOLOGIC TECHNIQUES; VACCINATION; VACCINES;

EID: 79959256405     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2011.01609.x     Document Type: Short Survey

References (53)

1. Araki, K., Turner, A.P., Shaffer, V.O., Gangappa, S., Keller, S.A., Bachmann, M.F., etal. (2009) mTOR regulates memory CD8 T-cell differentiation. Nature 460: 108-112.
2. + regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
3. Bevan, M.J. (2006) Cross-priming. Nat Immunol 7: 363-365.
4. Bluestone, J.A., and Abbas, A.K. (2003) Natural versus adaptive regulatory T cells. Nat Rev Immunol 3: 253-257.
5. Cardone, J., Le, F.G., Vantourout, P., Roberts, A., Fuchs, A., Jackson, I., etal. (2010) Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells. Nat Immunol 11: 862-871.
6. Coffman, R.L., Sher, A., and Seder, R.A. (2010) Vaccine adjuvants: putting innate immunity to work. Immunity 33: 492-503.
7. Darrah, P.A., Patel, D.T., De Luca, P.M., Lindsay, R.W., Davey, D.F., Flynn, B.J., etal. (2007) Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 13: 843-850.
8. Eisenbarth, S.C., Colegio, O.R., O'Connor, W., Sutterwala, F.S., and Flavell, R.A. (2008) Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453: 1122-1126.
9. Foulds, K.E., Rotte, M.J., and Seder, R.A. (2006) IL-10 is required for optimal CD8 T cell memory following Listeria monocytogenes infection. J Immunol 177: 2565-2574.
10. Gregory, S.H., Mott, S., Phung, J., Lee, J., Moise, L., McMurry, J.A., etal. (2009) Epitope-based vaccination against pneumonic tularemia. Vaccine 27: 5299-5306.
11. Hansen, S.G., Vieville, C., Whizin, N., Coyne-Johnson, L., Siess, D.C., Drummond, D.D., etal. (2009) Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat Med 15: 293-299.
12. Heurtault, B., Frisch, B., and Pons, F. (2010) Liposomes as delivery systems for nasal vaccination: strategies and outcomes. Expert Opin Drug Deliv 7: 829-844.
13. Hirao, L.A., Draghia-Akli, R., Prigge, J.T., Yang, M., Satishchandran, A., Wu, L., etal. (2011) Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge. J Infect Dis 203: 95-102.
14. Hiromatsu, K., Dascher, C.C., LeClair, K.P., Sugita, M., Furlong, S.T., Brenner, M.B., and Porcelli, S.A. (2002) Induction of CD1-restricted immune responses in guinea pigs by immunization with mycobacterial lipid antigens. J Immunol 169: 330-339.
15. Hoft, D.F., and Eickhoff, C.S. (2002) Type 1 immunity provides optimal protection against both mucosal and systemic Trypanosoma cruzi challenges. Infect Immun 70: 6715-6725.
16. Hoft, D.F., Brown, R.M., and Roodman, S.T. (1998) Bacille Calmette-Guerin vaccination enhances human γδ T cell responsiveness to mycobacteria suggestive of a memory-like phenotype. J Immunol 161: 1045-1054.
17. Hoft, D.F., Worku, S., Kampmann, B., Whalen, C.C., Ellner, J.J., Hirsch, C.S., etal. (2002) Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity. J Infect Dis 186: 1448-1457.
18. + CTL and B cell-mediated cross-priming. J Immunol 179: 6889-6900.
19. Kemper, C., and Atkinson, J.P. (2007) T-cell regulation: with complements from innate immunity. Nat Rev Immunol 7: 9-18.
20. + cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421: 388-392.
21. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8: 369-377.
22. Knickelbein, J.E., Khanna, K.M., Yee, M.B., Baty, C.J., Kinchington, P.R., and Hendricks, R.L. (2008) Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency. Science 322: 268-271.
23. Kunkel, E.J., and Butcher, E.C. (2002) Chemokines and the tissue-specific migration of lymphocytes. Immunity 16: 1-4.
24. Lin, F., Shen, X., McCoy, J.R., Mendoza, J.M., Yan, J., Kemmerrer, S.V., etal. (2011) A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle. Vaccine (in press).
25. + T-cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Path 2: e77.
26. Massa, M., Passalia, M., Manzoni, S.M., Campanelli, R., Ciardelli, L., Yung, G.P., etal. (2007) Differential recognition of heat-shock protein dnaJ-derived epitopes by effector and Treg cells leads to modulation of inflammation in juvenile idiopathic arthritis. Arthritis Rheum 56: 1648-1657.
27. Meister, G.E., Roberts, C.G., Berzofsky, J.A., and De Groot, A.S. (1995) Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences. Vaccine 13: 581-591.
28. Metkar, S.S., Menaa, C., Pardo, J., Wang, B., Wallich, R., Freudenberg, M., etal. (2008) Human and mouse granzyme A induce a proinflammatory cytokine response. Immunity 29: 720-733.
29. Migueles, S.A., Laborico, A.C., Shupert, W.L., Sabbaghian, M.S., Rabin, R., Hallahan, C.W., etal. (2002) HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 3: 1061-1068.
30. Mishra, N., Goyal, A.K., Tiwari, S., Paliwal, R., Paliwal, S.R., Vaidya, B., etal. (2010) Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers. Expert Opin Ther Pat 20: 661-679.
31. Moise, L., Buller, R.M.S., Schriewer, J., Lee, J., Frey, S., Weiner, D.B., etal. (2011) VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone. Vaccine 29: 501-511.
32. 2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol Rev 215: 59-76.
33. O'Shea, J.J., and Paul, W.E. (2010) Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327: 1098-1102.
34. Pulendran, B., Li, S., and Nakaya, H.I. (2010) Systems vaccinology. Immunity 33: 516-529.
35. Sallusto, F., Lenig, D., Forster, R., Lipp, M., and Lanzavecchia, A. (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
36. Sallusto, F., Geginat, J., and Lanzavecchia, A. (2004) Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22: 745-763.
37. Schneider, J., Gilbert, S.C., Blanchard, T.J., Hanke, T., Robson, K.J., Hannan, C.M., etal. (1998) Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat Med 4: 397-402.
38. Sette, A., and Sidney, J. (1998) HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. Curr Opin Immunol 10: 478-482.
39. Shen, Y., Zhou, D., Qiu, L., Lai, X., Simon, M., Shen, L., etal. (2002) Adaptive immune response of Vγ2Vδ2+ T cells during mycobacterial infections. Science 295: 2255-2258.
40. Sigmundsdottir, H., and Butcher, E.C. (2008) Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nat Immunol 9: 981-987.
41. Southwood, S., Sidney, J., Kondo, A., del Guercio, M.F., Appella, E., Hoffman, S., etal. (1998) Several common HLA-DR types share largely overlapping peptide binding repertoires. J Immunol 160: 3363-3373.
42. 2 T cells mediate protective tuberculosis immunity. J Immunol 181: 4471-4484.
43. Spolski, R., and Leonard, W.J. (2010) IL-21 and T follicular helper cells. Int Immunol 22: 7-12.
44. Stenger, S., Hanson, D.A., Teitlbaum, R., Dewan, P., Niazi, K.R., Froelich, C.J., etal. (1998) An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282: 121-125.
45. Swain, S. (1994) Generation and in vivo persistence of polarized Th1 and Th2 memory cells. Immunity 1: 543-552.
46. Truscott, S.M., Abate, G., Price, J.D., Kemper, C., Atkinson, J.P., and Hoft, D.F. (2010) CD46 engagement on human CD4+ T cells produces T regulatory type 1-like regulation of antimycobacterial T cell responses. Infect Immun 78: 5295-5306.
47. + T cells leading to immunodominance. J Immunol 180: 1737-1748.
48. Vincent, M.S., Gumperz, J.E., and Brenner, M.B. (2003) Understanding the function of CD1-restricted T cells. Nat Immunol 4: 517-523.
49. Wang, P., Sidney, J., Dow, C., Mothe, B., Sette, A., and Peters, B. (2008) A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Comput Biol 4: e1000048.
50. Wei, C.J., Boyington, J.C., McTamney, P.M., Kong, W.P., Pearce, M.B., Xu, L., etal. (2010) Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science 329: 1060-1064.
51. Willinger, T., Freeman, T., Hasegawa, H., McMichael, A.J., and Callan, M.F. (2005) Molecular signatures distinguish human central memory from effector memory CD8 T cell subsets. J Immunol 175: 5895-5903.
52. Zhou, L., Chong, M.M., and Littman, D.R. (2009) Plasticity of CD4+ T cell lineage differentiation. Immunity 30: 646-655.
53. Zhu, J., Yamane, H., and Paul, W.E. (2010) Differentiation of effector CD4 T cell populations. Annu Rev Immunol 28: 445-489.